She won it! The Max Foundation is thrilled to announce that Pat Garcia-Gonzalez has won the Union for International Cancer Control’s CEO Award for 2018!
The Union for International Cancer Control (UICC) is a membership organization that aims to reduce the global cancer burden and promote greater equity in cancer care. Each year the UICC grants awards that aim to identify and celebrate best practices and inspirational figures among their members.
Pat received the CEO Award at this year’s World Cancer Congress in Kuala Lumpur, for her tremendous contributions to equity in cancer care and her visionary leadership as Chief Executive Officer of The Max Foundation. She was cheered on by friends, colleagues, and Max team members from around the globe.
Said Pat: “It is such an honor to receive this award, but it is not only for me. It’s really for the entire Max team and for all our many partners. My thanks go out to them for their daily efforts in making The Max Foundation possible and working tirelessly to create a world where all people can face cancer with dignity and hope.”
Pat had been one of three finalists for the award, alongside Asem Mansour of King Hussein Cancer Center in Jordan, and Wondu Bekele Woldemariam of Mathiwos Wondu-YeEthiopia Cancer Society. Our thanks and congratulations go out to all three finalists.
The Max Foundation would like to thank all our partners – physicians, pharmaceutical manufacturers, distribution and diagnostics companies, donors and supporters, and of course, patient associations – we could not do what we do with you.
Most of all, we’d like to thank the 18 different patient associations from across Asia that sent letters in support of Pat’s nomination. You are the inspiration for all we do and we are so very grateful for your support.
Visit the UICC website to learn more about the awards, the finalists, and our collective work to reduce the global cancer burden.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 27 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
The Max Foundation Establishes Unprecedented Network of Leading Cancer Providers in LMIC
In an effort to strengthen health outcomes for patients in low resource settings, The Max Foundation and its subsidiary, MaxAid, have signed Collaboration Agreements with 140 individual hematologists and oncologists from leading National Cancer Institutes and clinics in 60 low and middle income countries. With the formal establishment of this network, The Max Foundation completes its validated supply chain into each of the countries, providing a safe environment through which to channel humanitarian donations of cancer treatment with end-to-end controls.
Spot On CML: Improving CML Diagnostics One Patient at a Time
February 21, 2018 · The Max Foundation and Dr. Jerry Radich of the Fred Hutchinson Cancer Research Center are partnering to help tackle the problem of access to accurate tests for chronic myeloid leukemia (CML) diagnostics in low- and middle-income countries through Spot On CML. Spot On CML is a low-cost, paper-based diagnostic testing method for CML, developed by Dr. Radich’s lab at Fred Hutch. Through a Spot On CML test, a physician spots a patient’s blood onto a paper test card and sends it to Dr. Radich’s lab for processing, where they perform accurate diagnostic testing on the samples even after weeks of transport. Once patients are diagnosed, The Max Foundation connects them with available treatments free of charge.
The Max Foundation Announces Multi-Stakeholder Collaboration to Improve Outcomes for People Living with Advanced Breast Cancer in Low-Resource Countries
Humanitarian Partnership for Access to Cancer Treatment (PACT) to launch in 5 countries in 2023 providing access to treatment and support for HR+/HER2- advanced breast cancer The Max Foundation, the ABC Global Alliance, the American Society of Clinical Pathology, Cepheid and Novartis AG are joining and committing resources to a unique collaboration Breast cancer is….
The Max Foundation uses cookies to improve your experience on our site. Please read our Privacy Policy for more information.Dismiss
